DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-285 Cr | ₹50 Cr | ₹193 Cr | ₹-1,045 Cr | ₹-816 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DIVIS LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-285 Cr |
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹193 Cr |
| Mar2023 | ₹-1,045 Cr |
| Mar2022 | ₹-816 Cr |
How is Net Cash Inflow / Outflow of DIVIS LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-285 Cr | Negative | |
| Mar2025 | ₹50 Cr | -74.09 | |
| Mar2024 | ₹193 Cr | Positive | |
| Mar2023 | ₹-1,045 Cr | Negative | |
| Mar2022 | ₹-816 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹250,419.6 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| MANKIND PHARMA | ₹100,364.0 Cr | 6.2% | 1.9% | -10.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 2.6% |
9.8% |
54.8% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses